This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

BioScrip Inc (BIOS)

NASDAQ: Health Care

Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 984.05M 842.20M 662.64M 1.82B
Cost of Sales 702.45M 554.57M 427.90M 1.49B
Gross Operating Profit 281.61M 287.63M 234.73M 324.05M
Selling, General, and Administrative Expenses 319.38M 254.00M 198.53M 260.73M
Research & Development 0.00 0.00 0.00 0.00
Operating Income before D & A (EBITDA) -37.78M 33.63M 36.21M 63.32M
Depreciation & Amortization 27.10M 22.48M 13.73M 16.93M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -24.26M -18.18M -4.05M 0.00
Special Income / Charges 7.36M 5.79M 0.00 0.00
Total Income Before Interest Expenses (EBIT) -97.42M -25.16M 13.29M 37.50M
Interest Expense 34.58M 25.91M 26.07M 28.31M
Pre-Tax Income -131.99M -51.07M -12.78M 9.20M
Income Taxes 11.39M 2.54M -4.44M 1.32M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -143.38M -53.61M -8.34M 7.87M
Net Income From Discontinued Operations -4.09M -16.05M 73.05M 0.00
Net Income From Total Operations -147.47M -69.65M 64.71M 7.87M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -147.47M -69.65M 64.71M 7.87M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-135.10M -35.49M -3.20M 16.76M
Preferred Dividends
Net Income Available To Common -143.38M -53.61M -8.34M 7.87M
Basic EPS from Continuing Ops. -2.09 -0.83 -0.15 0.14
Basic EPS from Discontinued Ops. -0.06 -0.25 1.30 0.00
Basic EPS from Total Operations -2.15 -1.08 1.15 0.14
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -2.15 -1.08 1.15 0.14
Basic Normalized Net Income/Share -1.97 -0.55 -0.06 0.31
EPS fr Continuing Ops. -2.09 -0.83 -0.15 0.14
EPS fr Discontinued Ops -0.06 -0.25 1.30 0.00
EPS fr Total Ops. -2.15 -1.08 1.15 0.14
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -2.15 -1.08 1.15 0.14
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.97 -0.55 -0.06 0.30
Dividends Paid per Share 0.00 0.00 0.00 0.00
BIOS News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for BIOS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET BIOS ANALYST REPORT

BIOS Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs